Catalyst Pharmaceutical (CPRX): Q3 2019 Earnings Snapshot

—  Catalyst Pharmaceutical (NASDAQ: CPRX) reported third quarter 2019 earnings of $0.13 per share, vs. $0.11 per share expected.

— Net
product revenue came in at $30.9 million, vs. $33.2 million expected.

—
Expects full year 2019 revenues of approx. $100 million. Revenues in 2020
projected to be in the range of $135 million to $155 million.

— CPRX
shares fell 5.2% immediately following the announcement.

Browse through our earnings calendar
and get all scheduled earnings announcements, analyst/investor conference and
much more!